ASP Isotopes Inc. Common Stock (ASPI)
Official siteBASIC MATERIALS • CHEMICALS • NASDAQ
Market Cap: $236.10M
Last updated: Nov 17, 2026 at 4:40 PM ET
ASP Isotopes Inc. Common Stock (ASPI) Statistics
ASP Isotopes Inc. Common Stock (ASPI) has a market cap of $236.10M and an enterprise value of $173.25M. Revenue grew 552.44% over the last 12 months from the 12 months before. It kept -435.28% of revenue as net income over the last 12 months.
Total Valuation
Enterprise value is 26.62% below the market cap, as cash exceeds debt.
| Market Cap | $236.10M |
|---|---|
| Enterprise Value | $173.25M |
| Latest price (Nov 17, 2026) | $1.37 |
Key Dates
The next earnings report is expected on Nov 17, 2026, covering the quarter ending Sep 30, 2026.
| Next Earnings Date | Nov 17, 2026 (expected) |
|---|---|
| Last Earnings Date | Aug 14, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 6.3x and 0.6x. Its year-end P/S ranged from 27.3x to 202.2x from 2023 to 2025.
| P/S Ratio | 6.3x |
|---|---|
| Forward P/S | 11.8x |
| P/B Ratio | 0.6x |
| P/TBV Ratio | 0.6x |
Price Statistics
The stock is down 83.11% over 52 weeks and trades 44.31% below its 50-day average.
| Beta (1Y) | 3.71 |
|---|---|
| 52-Week Change | -83.11% |
| 1-Month Change | -33.33% |
| 3-Month Change | -66.50% |
| 6-Month Change | -71.69% |
| Total Return (1Y) | -83.11% |
| Total Return (3Y CAGR) | -7.30% |
| Return vs SPY (1Y) | -93.60% |
| Max Drawdown (1Y) | -83.84% |
| Max Drawdown (3Y) | -90.25% |
| Sharpe Ratio (1Y) | -1.74 |
| Correlation with SPY (1Y) | 0.52 |
| 50-Day Average | $2.46 |
| 200-Day Average | $4.52 |
| 52-Week Range | $1.53 to $8.60 |
| RSI (14 Days) | 28.8 |
| Average Volume (20 Days) | 3.77M |
Financial Position
Current assets cover 3.44x current liabilities, and total debt is 0.40x shareholder equity.
| Current Ratio | 3.44x |
|---|---|
| Quick Ratio | 3.42x |
| Debt / Equity | 0.40x |
| Interest Coverage | 41.04x |
Returns and Efficiency
Return on invested capital is -35.10% and return on equity is -38.74% over the last 12 months.
| Return on Equity (ROE) | -38.74% |
|---|---|
| Return on Assets (ROA) | -25.15% |
| Return on Invested Capital (ROIC) | -35.10% |
| ROE (5Y Average) | -67.97% |
| ROA (5Y Average) | -40.34% |
| Asset Turnover | 0.08x |
| Inventory Turnover | 16.44x |
| Receivables Turnover | 9.85x |
| Cash Conversion Cycle | -52 days |
Scores
ASPI has an Altman Z-Score of -0.75, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -0.75 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $31.09M over the last 12 months.
| Revenue | $31.09M |
|---|---|
| Revenue Growth (YoY) | +552.44% |
| Gross Profit | $6.02M |
| Operating Income | -$124.62M |
| Pretax Income | -$153.72M |
| Net Income | -$135.31M |
| Reported EPS (TTM) | -$0.89 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 64.91% of the $538.13M in total assets.
| Cash and Equivalents | $201.66M |
|---|---|
| Total Debt | $138.82M |
| Net Cash | $62.84M |
| Net Cash Per Share | $0.44 |
| Working Capital | $167.85M |
| Shareholder Equity | $349.30M |
| Book Value Per Share | $2.44 |
| Tangible Book Value | $342.25M |
| Tangible Book Per Share | $2.39 |
| Total Assets | $538.13M |
| Total Liabilities | $178.84M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $15.97M of capital spending, operating cash flow left -$100.27M of free cash flow.
| Operating Cash Flow | -$84.30M |
|---|---|
| Capital Expenditures | $15.97M |
| Free Cash Flow | -$100.27M |
| FCF Per Share | -$0.65 |
| Depreciation and Amortization | $6.91M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -400.88%.
| Gross Margin | 19.37% |
|---|---|
| Operating Margin | -400.88% |
| Pretax Margin | -494.50% |
| Net Margin | -435.28% |
| FCF Margin | -322.56% |
Growth
| Book Value Per Share Growth (2Y CAGR) | +134.27% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | +158.39% |
Dividends and Yields
ASPI does not pay a dividend. Its free cash flow yield is -51.04%.
| FCF Yield | -51.04% |
|---|---|
| Buyback Yield | -111.96% |
| Shareholder Yield | -111.96% |
Peer Position
Against 10 similar companies, ASPI has the highest P/S.
P/S RatioPeer median 0.7x
ROICPeer median 0.44%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +4.11%
| P/S Ratio | 6.3x vs 0.7x median |
|---|---|
| ROIC | -35.10% vs 0.44% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +552.44% vs +4.11% median |
Analyst Forecast
Consensus estimates put revenue growth at 55.66% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +55.66% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About ASPI
What is ASPI's market cap?
ASP Isotopes Inc. Common Stock has a market cap of $236.10M. Its enterprise value, which adds debt and subtracts cash, is $173.25M.
How many shares of ASPI are outstanding?
ASP Isotopes Inc. Common Stock has 143.39M shares outstanding. The count is up 61.92% from a year earlier.
Does ASPI pay a dividend?
No. ASP Isotopes Inc. Common Stock does not pay a dividend.
How much debt does ASPI have?
ASP Isotopes Inc. Common Stock has $138.82M of total debt and $201.66M of cash and equivalents, a net cash position of $62.84M.
ASPI pages: Overview, Charting, Forecast, Financials, Statistics, Valuation, Competitors